We are live on
!
Find out more
CC
Callan Capital Portfolio holdings
AUM
$1.35B
Turnover
17.35%
1-Year Est. Return
8.35%
This Fund
S&P 500
This Quarter
Est. Return
+11.93%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$470M
AUM Growth
+$29.3M
(+6.7%)
Cap. Flow
-$17.8M
Cap. Flow
% of AUM
-3.78%
Top 10 Holdings %
Top 10 Hldgs %
73.69%
Holding
76
New
3
Increased
26
Reduced
21
Closed
8
Avg Time Held
1.2
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Global Tactical Commodity Strategy Fund
FTGC
|
+$4.72M |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$4.01M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$3.34M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$2.89M |
| 5 |
Invesco DB Commodity Index Tracking Fund
DBC
|
+$916K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShare MSCI Eurozone ETF
EZU
|
+$2.93M |
| 2 |
CFN
CAREFUSION CORPORATION
CFN
|
+$2.24M |
| 3 |
Halozyme
HALO
|
+$1.94M |
| 4 |
Regulus Therapeutics
RGLS
|
+$1.28M |
| 5 |
Alerian MLP ETF
AMLP
|
+$1.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 97.16% |
| 2 | Healthcare | 1.75% |
| 3 | Real Estate | 0.45% |
| 4 | Consumer Staples | 0.2% |
| 5 | Materials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.75B
| $2.35M | 0.5% |
36,653
-209
| -0.6% | -$13.1K |
2013 Q2
7 quarters
|
|
27
iShares Russell 1000 ETF
IWB
$49.2B
| $1.92M | 0.41% |
16,584
-857
| -5% | -$99K |
2013 Q2
7 quarters
|
|
28
Biogen
BIIB
$34.8B
| $1.91M | 0.41% |
4,526
| – | – |
2013 Q2
7 quarters
|
|
29
iShares US Financials ETF
IYF
$3.84B
| $1.89M | 0.4% |
42,504
-1,562
| -4% | -$69.4K |
2013 Q2
7 quarters
|
|
30
iShares CMBS ETF
CMBS
$437M
| $1.59M | 0.34% |
30,416
-4,239
| -12% | -$220K |
2013 Q3
6 quarters
|
|
31
State Street SPDR Bloomberg Emerging Markets Local Bond ETF
EBND
$2.26B
| $1.58M | 0.34% |
58,141
| – | – |
2013 Q4
5 quarters
|
|
32
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.38B
| $1.55M | 0.33% |
53,235
-4,423
| -8% | -$129K |
2013 Q3
6 quarters
|
|
33
State Street Materials Select Sector SPDR ETF
XLB
$7.99B
| $1.5M | 0.32% |
61,530
-1,002
| -2% | -$24.8K |
2013 Q2
7 quarters
|
|
34
DELISTED
BIOMED REALTY TRUST INC
BMR
| $1.46M | 0.31% |
64,584
+4,415
| +7% | +$101K |
2014 Q3
2 quarters
|
|
35
State Street Multi-Asset Real Return ETF
RLY
$1.43B
| $1.41M | 0.3% |
53,936
+204
| +0.4% | +$5.44K |
2013 Q4
5 quarters
|
|
36
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $1.33M | 0.28% |
59,956
+30
| +0.1% | +$693 |
2013 Q2
7 quarters
|
|
37
Global X MLP & Energy Infrastructure ETF
MLPX
$3.47B
| $1.33M | 0.28% |
23,609
-2,058
| -8% | -$113K |
2014 Q3
2 quarters
|
|
|
SGYP
38
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $1.21M | 0.26% |
261,222
+19,877
| +8% | +$64.6K |
2013 Q4
5 quarters
|
|
|
ARNA
39
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.15M | 0.24% |
26,200
+8,095
| +45% | +$376K |
2014 Q2
3 quarters
|
|
|
SQNM
40
DELISTED
SEQUENOM INC NEW
SQNM
| $1.05M | 0.22% |
266,477
| – | – |
2013 Q3
6 quarters
|
|
|
ZVO
41
DELISTED
Zovio Inc. Common Stock
ZVO
| $950K | 0.2% |
98,418
-30,000
| -23% | -$302K |
2014 Q1
4 quarters
|
|
|
42
Halozyme
HALO
$13.8B
| $920K | 0.2% |
64,431
-134,799
| -68% | -$1.94M |
2013 Q2
7 quarters
|
|
43
Vanguard Morningstar Large-Cap ETF
VV
$54.8B
| $901K | 0.19% |
9,466
| – | – |
2014 Q1
4 quarters
|
|
|
44
Invesco DB Commodity Index Tracking Fund
DBC
$1.97B
| $888K | 0.19% |
+52,021
| New | +$916K |
2015 Q1
0 quarters
|
|
|
AXJL
45
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
| $862K | 0.18% |
12,842
| – | – |
2014 Q4
1 quarter
|
|
46
Neurocrine Biosciences
NBIX
$13.9B
| $794K | 0.17% |
20,000
-7,365
| -27% | -$263K |
2013 Q4
5 quarters
|
|
|
MON
47
DELISTED
Monsanto Co
MON
| $686K | 0.15% |
6,098
| – | – |
2014 Q2
3 quarters
|
|
48
Alexandria Real Estate Equities
ARE
$7.29B
| $638K | 0.14% |
6,509
| – | – |
2014 Q2
3 quarters
|
|
|
KND
49
DELISTED
Kindred Healthcare
KND
| $630K | 0.13% |
26,468
| – | – |
2014 Q3
2 quarters
|
|
50
iShares MSCI KLD 400 Social ETF
DSI
$5.53B
| $507K | 0.11% |
13,138
-2,294
| -15% | -$88.1K |
2013 Q2
7 quarters
|
|
Similar funds
PRO
MBA
SIA
AP
MW
SBIA
LC
TW
Callan Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Callan Capital held 76 positions worth $470M, up 6.7% from $441M the previous quarter. Its ten largest holdings account for 74% of the portfolio.
Callan Capital withdrew a net $17.8M in Q1 2015, closing 8 positions and reducing 21 holdings. Its most notable exit was iShare MSCI Eurozone ETF, an estimated $2.93M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 97% of assets, up from 96% a quarter earlier, followed by Healthcare and Real Estate.
Against the trend, Callan Capital opened a new position in Invesco DB Commodity Index Tracking Fund worth $888K.
- Callan Capital's largest Q1 2015 buy was Invesco DB Commodity Index Tracking Fund: 52,021 shares worth $888K.
- Callan Capital added most to First Trust Global Tactical Commodity Strategy Fund in Q1 2015, an estimated $4.72M increase.
- Callan Capital's biggest Q1 2015 reduction was Halozyme, cutting an estimated $1.94M.
- Callan Capital fully exited iShare MSCI Eurozone ETF in Q1 2015, selling an estimated $2.93M.
- Callan Capital's ten largest holdings make up 74% of its $470M portfolio in Q1 2015.
- Callan Capital opened 3 new positions and closed 8 in Q1 2015.
- Callan Capital's portfolio value rose 6.7% quarter-over-quarter to $470M.
Based on Callan Capital's 13F filing for Q1 2015, filed 11 May 2015.